findmyKOL

Jason Matos, MD

Basic profile

Beth Israel Deaconess Medical Center

ORCIDNPI
RegionBoston, MA · NortheastSpecialtyCardiovascular DiseaseFocusCardiology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2025Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Jason Matos is a Cardiology physician affiliated with Beth Israel Deaconess Medical Center. OpenAlex indexes 51 publications with 524 citations (h-index 12).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
51publications

Distinct works indexed by OpenAlex, matched via ORCID.

524citations

Total citations across indexed works.

12h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
1companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

330 Brookline Ave
Boston, MA 022155400

Telephone

617-667-7000

Registry record last updated 31 Jul 2019.

View the NPPES registry record

Industry payments

1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    79.6%
    Statin19.7%
    Atorvastatin Calcium53%Rosuvastatin Calcium43%Pravastatin Sodium4%
    Part D<11 patients
    Beta blocker18.4%
    Metoprolol Succinate76%Carvedilol21%Propranolol Hcl Er3%
    Part D<11 patients

    + 14 more classes in this area

  • Blood & clotting

    12.1%
    Factor Xa inhibitor9.4%
    Eliquis75%Xarelto25%
    Part D54 patients
    P2Y12 inhibitor2.3%
    Clopidogrel100%
    Part D22 patients

    + 1 more class in this area

  • Metabolism & gastrointestinal

    7.3%
    SGLT2 inhibitor4.9%
    Jardiance67%Farxiga33%
    Part D<11 patients
    GLP-1 receptor agonist1.9%
    Wegovy43%Mounjaro30%Ozempic26%
    Part D<11 patients

    + 1 more class in this area

Where care is delivered (Part B)89.9% facility · 10.1% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”